SG Americas Securities LLC Makes New $379,000 Investment in Aspen Aerogels, Inc. (NYSE:ASPN)

SG Americas Securities LLC bought a new position in Aspen Aerogels, Inc. (NYSE:ASPN) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 13,700 shares of the construction company’s stock, valued at approximately $379,000.

Several other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Aspen Aerogels by 5.1% during the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after buying an additional 175,906 shares in the last quarter. Hood River Capital Management LLC grew its stake in Aspen Aerogels by 12.2% during the 1st quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock valued at $58,088,000 after acquiring an additional 357,895 shares in the last quarter. Driehaus Capital Management LLC increased its holdings in shares of Aspen Aerogels by 130.4% in the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock valued at $51,439,000 after purchasing an additional 1,220,724 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Aspen Aerogels by 21.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company’s stock worth $32,790,000 after purchasing an additional 240,921 shares in the last quarter. Finally, American Century Companies Inc. lifted its position in shares of Aspen Aerogels by 562.3% in the second quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock worth $18,382,000 after purchasing an additional 654,350 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages recently commented on ASPN. Roth Mkm reaffirmed a “buy” rating and set a $36.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, August 21st. B. Riley raised shares of Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, June 25th. Barclays started coverage on Aspen Aerogels in a report on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price objective for the company. HC Wainwright restated a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday. Finally, TD Cowen raised their price target on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $29.70.

Aspen Aerogels Price Performance

Shares of NYSE:ASPN opened at $21.60 on Friday. The stock has a market capitalization of $1.64 billion, a P/E ratio of -49.08 and a beta of 2.16. The business has a 50-day moving average of $26.00 and a two-hundred day moving average of $24.35. Aspen Aerogels, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $33.15. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. The firm had revenue of $117.80 million during the quarter, compared to analyst estimates of $101.99 million. During the same period in the previous year, the company earned ($0.22) EPS. The company’s revenue for the quarter was up 144.4% on a year-over-year basis. On average, equities research analysts predict that Aspen Aerogels, Inc. will post 0.21 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.